Tick (check) box to add article to PDF "basket"
Without catalysts, humans wouldn't have got far. They trigger many of the processes on which we rely, from age-old mechanisms deep down in our cells to the production of contemporary consumer goods. They could also smooth our path towards a sustainable future. EU-funded researcher Xile Hu has delivered promising advances.
Published: 21 August 2015
EU-funded researchers are developing a highly accurate, cost-effective and simple-to-use test for malaria. The innovative diagnostic tool, which is being refined and tested in Africa and Asia, promises to save lives through early detection while advancing efforts to eradicate the deadly mosquito-borne disease.
Published: 19 August 2015
Researchers are blazing a trail towards personalised medicine in cancer care. This will mean the provision of new immunotherapy treatments targeting some of the most complicated conditions. In line with this approach an EU-funded project is developing new technologies to help doctors provide targeted, individual treatments. It has so far conducted clinical trials involving eight melanoma patients to demonstrate the potential of this approach.
Published: 18 August 2015
Lung cancer is the leading killer of all cancers worldwide. The outcome depends heavily on when the disease is diagnosed. But therapeutic strategies are also key, and those currently available are only making modest inroads into mortality rates. The EU-funded project WINTHER set out to improve methods for predicting the efficacy of drugs in cancer patients in a ground-breaking new approach to targeted therapies.
Published: 17 August 2015
An EU-funded project is attempting to validate a prototype test designed to predict which combination therapy would best suit individual patients with colorectal cancer, the most common form of cancer in Europe. The test is expected to lengthen the life expectancy for those with this aggressive form of cancer by indicating the most effective treatment combination for individual patients.
Published: 13 August 2015
An artificial intelligence-based system developed by EU-funded researchers for the plastic injection moulding industry promises to boost productivity, cut time to market, reduce scrap and lower costs. This comes at a time of rapid change and rising competition for one of Europe's largest manufacturing sectors.
Published: 10 August 2015
Breast cancer is a leading cause of death for women, despite screening programmes cutting mortality rates. EU-funded researchers have developed new tools for personalised screening programmes to improve detection and prognosis - several of which are ready for use.
Published: 29 July 2015
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide.
Published: 28 July 2015
Experts predict that, in the coming years, a higher frequency and intensity of heat waves could lead to an increase of fatalities in the elderly population. To help prevent this, a Marie Curie research fellow, Dr. Andreas D. Flouris, studied and explained the sequence of events leading to heat stroke. His research work was as part of the EU-funded project THERMOMICS.
Published: 17 July 2015
In Europe, some 463 000 women are diagnosed with breast cancer each year, making it the most common form of cancer in women. Depending on certain conditions, different drug combinations will be more - or less - effective. The EU-funded RESPONSIFY project has identified these conditions.
Published: 16 July 2015